» Articles » PMID: 23077661

Activation of AMPK by the Putative Dietary Restriction Mimetic Metformin is Insufficient to Extend Lifespan in Drosophila

Overview
Journal PLoS One
Date 2012 Oct 19
PMID 23077661
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

The biguanide drug, metformin, commonly used to treat type-2 diabetes, has been shown to extend lifespan and reduce fecundity in C. elegans through a dietary restriction-like mechanism via the AMP-activated protein kinase (AMPK) and the AMPK-activating kinase, LKB1. We have investigated whether the longevity-promoting effects of metformin are evolutionarily conserved using the fruit fly, Drosophila melanogaster. We show here that while feeding metformin to adult Drosophila resulted in a robust activation of AMPK and reduced lipid stores, it did not increase lifespan in either male or female flies. In fact, we found that when administered at high concentrations, metformin is toxic to flies. Furthermore, no decreases in female fecundity were observed except at the most toxic dose. Analysis of intestinal physiology after metformin treatment suggests that these deleterious effects may result from disruptions to intestinal fluid homeostasis. Thus, metformin appears to have evolutionarily conserved effects on metabolism but not on fecundity or lifespan.

Citing Articles

Dysfunctional BCAA degradation triggers neuronal damage through disrupted AMPK-mitochondrial axis due to enhanced PP2Ac interaction.

Wu S, Chen Y, Su S, Fang P, Liu R, Tsai H Commun Biol. 2025; 8(1):105.

PMID: 39838082 PMC: 11751115. DOI: 10.1038/s42003-025-07457-6.


Too old for healthy aging? Exploring age limits of longevity treatments.

Chaudhari P, Ermolaeva M NPJ Metab Health Dis. 2024; 2(1):37.

PMID: 39678297 PMC: 11638076. DOI: 10.1038/s44324-024-00040-3.


Anti-diabetic drug pioglitazone reduces Islet amyloid aggregation overload in the Drosophila neuronal cells.

Sharma K, Rai P, Maurya S, Tapadia M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39636405 DOI: 10.1007/s00210-024-03632-4.


Pharmacology of Aging: as a Tool to Validate Drug Targets for Healthy Lifespan.

Dos Santos E, Cocheme H Aging Biol. 2024; 2(1):20240034.

PMID: 39346601 PMC: 7616647. DOI: 10.59368/agingbio.20240034.


The genetic advantage of healthy centenarians: unraveling the central role of NLRP3 in exceptional healthspan.

Verlinden S Front Aging. 2024; 5:1452453.

PMID: 39301197 PMC: 11410711. DOI: 10.3389/fragi.2024.1452453.


References
1.
Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K, Beasley T . Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201-4. PMC: 2812811. DOI: 10.1126/science.1173635. View

2.
Clancy D, Gems D, Hafen E, Leevers S, Partridge L . Dietary restriction in long-lived dwarf flies. Science. 2002; 296(5566):319. DOI: 10.1126/science.1069366. View

3.
Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8):1167-74. PMC: 209533. DOI: 10.1172/JCI13505. View

4.
Anisimov V, Egormin P, Bershtein L, Zabezhinskii M, Piskunova T, Popovich I . Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice. Bull Exp Biol Med. 2005; 139(6):721-3. DOI: 10.1007/s10517-005-0389-9. View

5.
Anisimov V, Berstein L, Egormin P, Piskunova T, Popovich I, Zabezhinski M . Metformin slows down aging and extends life span of female SHR mice. Cell Cycle. 2008; 7(17):2769-73. DOI: 10.4161/cc.7.17.6625. View